| Transfusion requirements in surgical oncology patients: a prospective, randomized controlled trial J Pinheiro de Almeida, JL Vincent, FR Barbosa Gomes Galas, ... Anesthesiology 122 (1), 29-38, 2015 | 260 | 2015 |
| Diretrizes para detecção precoce do câncer de mama no Brasil. II-Novas recomendações nacionais, principais evidências e controvérsias A Migowski, GA Silva, MBK Dias, MDPE Diz, DR Sant’Ana, P Nadanovsky Cadernos de Saúde Pública 34, e00074817, 2018 | 198 | 2018 |
| Homologous recombination deficiency in ovarian cancer: a review of its epidemiology and management RR da Cunha Colombo Bonadio, RN Fogace, VC Miranda, MPE Diz Clinics 73, e450s, 2018 | 141 | 2018 |
| Palliative care in the global setting: ASCO resource-stratified practice guideline H Osman, S Shrestha, S Temin, ZV Ali, RA Corvera, HD Ddungu, ... Journal of global oncology 4, 1-24, 2018 | 139 | 2018 |
| I Diretriz Brasileira de cardio-oncologia da Sociedade Brasileira de Cardiologia R Kalil Filho, LA Hajjar, F Bacal, PM Hoff, MP Diz, F Galas Arquivos brasileiros de cardiologia 96, 01-52, 2011 | 126 | 2011 |
| Liberal versus restrictive transfusion strategy in critically ill oncologic patients: the transfusion requirements in critically ill oncologic patients randomized controlled trial FS Bergamin, JP Almeida, G Landoni, FRBG Galas, JT Fukushima, ... Critical care medicine 45 (5), 766-773, 2017 | 121 | 2017 |
| Guidelines for early detection of breast cancer in Brazil. II-New national recommendations, main evidence, and controversies A Migowski, MBK Dias, MDPE Diz, DR Sant’Ana, P Nadanovsky Cadernos de saude publica 34, e00074817, 2018 | 111 | 2018 |
| Neoadjuvant chemotherapy with six cycles of carboplatin and paclitaxel in advanced ovarian cancer patients unsuitable for primary surgery: safety and effectiveness V da Costa Miranda, ÂB de Souza Fęde, CH Dos Anjos, JR da Silva, ... Gynecologic oncology 132 (2), 287-291, 2014 | 98 | 2014 |
| A Biomarker-enriched, Randomized Phase II Trial of Adavosertib (AZD1775) Plus Paclitaxel and Carboplatin for Women with Platinum-sensitive TP53-mutant … AM Oza, M Estevez-Diz, EM Grischke, M Hall, F Marmé, D Provencher, ... Clinical Cancer Research 26 (18), 4767-4776, 2020 | 92 | 2020 |
| Pregnancy After Breast Cancer in Patients With Germline BRCA Mutations M Lambertini, L Ameye, AS Hamy, A Zingarello, PD Poorvu, E Carrasco, ... Journal of Clinical Oncology 38 (26), 3012-3023, 2020 | 89 | 2020 |
| Neoadjuvant chemotherapy with cisplatin and gemcitabine followed by chemoradiation versus chemoradiation for locally advanced cervical cancer: a randomized phase II trial SCS da Costa, RC Bonadio, FCG Gabrielli, AS Aranha, MLN Dias Genta, ... Journal of Clinical Oncology 37 (33), 3124-3131, 2019 | 86 | 2019 |
| Phase II study of the safety and efficacy of the anti-PD-1 antibody balstilimab in patients with recurrent and/or metastatic cervical cancer DM O'Malley, A Oaknin, BJ Monk, F Selle, C Rojas, L Gladieff, D Berton, ... Gynecologic oncology 163 (2), 274-280, 2021 | 85 | 2021 |
| Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil S Maistro, N Teixeira, G Encinas, MLH Katayama, VDT Niewiadonski, ... BMC cancer 16, 1-8, 2016 | 77 | 2016 |
| Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup I Vergote, A Gonzalez-Martin, D Lorusso, C Gourley, MR Mirza, JE Kurtz, ... The Lancet Oncology 23 (8), e374-e384, 2022 | 72 | 2022 |
| Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae in cancer patients MP Freire, LC Pierrotti, HHC Filho, KY Ibrahim, A Magri, PR Bonazzi, ... European Journal of Clinical Microbiology & Infectious Diseases 34, 277-286, 2015 | 72 | 2015 |
| Consenso brasileiro sobre manejo da dor relacionada ao câncer EG Wiermann, MPE Diz, R Caponero, PSM Lages, CZS Araújo, ... Revista Brasileira de Oncologia Clínica Vol 10 (38), 2014 | 59 | 2014 |
| Brazilian Cardio-oncology Guideline–2020 LA Hajjar, IBSS Costa, MACQ Lopes, PMG Hoff, MDPE Diz, ... Arquivos Brasileiros de Cardiologia 115, 1006-1043, 2020 | 55 | 2020 |
| Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial BJ Monk, T Toita, X Wu, JCV Limón, R Tarnawski, M Mandai, ... The Lancet Oncology 24 (12), 1334-1348, 2023 | 52 | 2023 |
| Oncologic concerns regarding laparoscopic cytoreductive surgery in patients with advanced ovarian cancer submitted to neoadjuvant chemotherapy G Favero, N Macerox, T Pfiffer, C Köhler, V da Costa Miranda, ... Oncology 89 (3), 159-166, 2015 | 51 | 2015 |
| Mismatch repair and microsatellite instability testing for immune checkpoint inhibitor therapy: ASCO endorsement of College of American Pathologists guideline P Vikas, H Messersmith, C Compton, L Sholl, RR Broaddus, A Davis, ... Journal of Clinical Oncology 41 (10), 1943-1948, 2023 | 49 | 2023 |
